甲氨蝶呤二钠盐(CAS 7413-34-5):分子式 C20H20N8Na2O5、分子量 498.4;类别 医药中间体及原料药。
登记用途:Methotrexate is indicated in the treatment of gestational choriocarcinoma、chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia、methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer、epidermoid cancers of the head and neck、advanced mycosis fungoides (cutaneous T cell lymphoma)、and lung cancer。
甲氨蝶呤二钠盐 是一种医药中间体或原料药类化合物,登记 CAS 号为 7413-34-5,分子式 C20H20N8Na2O5(分子量 498.4),归属于医药中间体及原料药大类化工原料。
登记 CAS 号:7413-34-5
其分子式 C20H20N8Na2O5 由 20 个碳、20 个氢、8 个氮、2 个钠、5 个氧 组成。
别名/同义词:甲氨蝶呤二钠盐 · Methotrexate disodium salt
所属分类:医药中间体及原料药
甲氨蝶呤二钠盐 的 CAS 登记号为 7413-34-5。
分子式 C20H20N8Na2O5,分子量 498.4。
别名/同义词:甲氨蝶呤二钠盐、Methotrexate disodium salt。
登记用途:Methotrexate is indicated in the treatment of gestational choriocarcinoma、chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia、methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer、epidermoid cancers of the head and neck、advanced mycosis fungoides (cutaneous T cell lymphoma)、and lung cancer。
所属分类:医药原料。
请在联系页面提交产品名称、CAS 号与数量,我们作为采购代理在国内及跨境渠道为您寻源比价,安排试样与批次采购,下单前提供 COA 与合规文件。
包装按订单确认,从实验室小包装到吨袋大货,随订单安排而非在页面上写死。每批随货附 COA 分析证书,可另提供 MSDS;若终端用途带有法规限度(食品接触、药品或化妆品),请在询价时说明执行标准,等级按该标准确定。
甲氨蝶呤二钠盐(CAS 7413-34-5)的公开数据库记录,列此仅供独立核对。
| Reported hazard statements | H301 (100%), H311 (98.1%), H315 (100%), H319 (100%), H331 (98.1%), H335 (98.1%), H340 (98.1%), H360 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H311 (98.1%): Toxic in contact with skin [Danger Acute toxicity, dermal]
| CAS Registry Number | 7413-34-5 |
|---|---|
| PubChem CID | 11329481 |
| 分子式 | C20H20N8Na2O5 |
| 分子量 | 498.14 g/mol |
| IUPAC 名称 | disodium;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioate |
| InChIKey | DASQOOZCTWOQPA-GXKRWWSZSA-L |
| UNII(FDA) | 3IG1E710ZN |
| ChEBI 编号 | CHEBI:50679 |
Methotrexate disodium salt; 7413-34-5; METHOTREXATE SODIUM; Sodium methotrexate; Disodium methotrexate; Abitrexate; Trexall; Methotrexate Lpf; Folex Pfs; Mexate-Aq Preserved; Mexate-Aq; Methotrexate sodium salt; Methotrexate, Sodium Salt; Methotrexate (as disodium); ADX-2191 SODIUM; Methotrexate Preservative Free
| 分子量 | 498.4 |
|---|---|
| 氢键供体数 | 3 |
| 氢键受体数 | 12 |
| 可旋转键数 | 7 |
| 精确质量 | 498.13520433 |
| 单同位素质量 | 498.13520433 |
| 拓扑极性表面积 | 216 |
| 重原子数 | 35 |
| 形式电荷 | 0 |
| 复杂度 | 693 |
Methotrexate disodium salt is identified by CAS 7413-34-5, molecular formula C20H20N8Na2O5 and molecular weight 498.14 g/mol. UNII 3IG1E710ZN; ChEBI 50679; InChIKey DASQOOZCTWOQPA-GXKRWWSZSA-L.
数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。
English page: Methotrexate disodium salt